Company intelligence / Profile preview

SmartHealth Holdings, Inc.

Ownership: Private
Development stage: Other

Overview

SmartHealth Holdings, Inc. has developed and commercialized innovative diagnostic technologies including slide-free digital pathology imaging and the SmartVascular Dx platform. Their vascular diagnostics tool has been used by over 200,000 patients with demonstrated sensitivity and specificity in detecting vascular inflammation. The company is also advancing oncology diagnostics aimed at early cancer detection and improved treatment strategies.

Therapeutic areas: OncologyCardiovascular
Modalities: Digital diagnostics platformsImaging systems for pathology (slide-free digital imaging)Vascular diagnostic toolsOncology diagnostics solutions
Industry: Pathology

Beyond the preview

Go deeper on SmartHealth Holdings, Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SmartHealth Holdings, Inc..

Explore the full profile